Company intelligence / Profile preview

AM2PAT

Angier, North Carolina, United States
Ownership
Private
Development stage
Other
01

Overview

AM2PAT Inc. was a North Carolina-based manufacturer of pre-filled heparin and saline syringes that became the center of a major public health crisis in 2007 and 2008. The company's products were found to be contaminated with Serratia marcescens bacteria due to severe manufacturing violations and a lack of proper sterility testing. This contamination resulted in at least five deaths and over 300 infections across multiple states, leading to a massive nationwide recall. Following a federal investigation, the company was shut down, and its manufacturing facility in Angier, North Carolina, was closed. Several top executives were sentenced to prison for fraud and distributing adulterated medical products, while the CEO, Dushyant Patel, fled the country to avoid prosecution.

Therapeutic areas
CardiovascularOther
Modalities
Small moleculeDevice
Industry
Consumable Medical Devices
02

Partnerships

B. Braun Medical

Beyond the preview

Go deeper on AM2PAT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AM2PAT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call